UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Predictors of Long‐Term Renal Outcome in Lupus Nephritis Trials: Lessons Learned from the Euro‐Lupus Nephritis Cohort

Arthritis & rheumatology (Hoboken, N.J.), 2015-05, Vol.67 (5), p.1305-1313

2015

Volltextzugriff (PDF)

A CD8 + NK cell transcriptomic signature associated with clinical outcome in relapsing remitting multiple sclerosis

Nature communications, 2021-01, Vol.12 (1), p.635-635, Article 635

2021

Volltextzugriff (PDF)

Restoring the balance: immunotherapeutic combinations for autoimmune disease

Disease models & mechanisms, 2014-05, Vol.7 (5), p.503-513

2014

Volltextzugriff (PDF)

Immunosuppression causes dynamic changes in expression QTLs in psoriatic skin

Nature communications, 2023-10, Vol.14 (1), p.6268-17, Article 6268

2023

Volltextzugriff (PDF)

Approaches to Establishing Tolerance in Immune Mediated Diseases

Frontiers in immunology, 2021-09, Vol.12, p.744804-744804

2021

Volltextzugriff (PDF)

Phase II Randomized Trial of Rituximab Plus Cyclophosphamide Followed by Belimumab for the Treatment of Lupus Nephritis

Arthritis & rheumatology (Hoboken, N.J.), 2021-01, Vol.73 (1), p.121-131

2021

Volltextzugriff (PDF)

Effect of Costimulatory Blockade With Abatacept After Ustekinumab Withdrawal in Patients With Moderate to Severe Plaque Psoriasis: The PAUSE Randomized Clinical Trial

JAMA dermatology (Chicago, Ill.), 2021-11, Vol.157 (11), p.1306

2021

Volltextzugriff (PDF)

ACCLAIM: A randomized trial of abatacept (CTLA4-Ig) for relapsing-remitting multiple sclerosis

Multiple sclerosis, 2017-04, Vol.23 (5), p.686-695

2017

Volltextzugriff (PDF)

Solving the puzzle of autoimmunity: critical questions

F1000 prime reports, 2015-02, Vol.7, p.17-17

2015

Volltextzugriff (PDF)

The immune cell landscape in kidneys of patients with lupus nephritis

Nature immunology, 2019-07, Vol.20 (7), p.902-914

2019

Volltextzugriff (PDF)

Profiling CIS progression and stability using RNA-seq single-cell analysis in peripheral blood mononuclear cells

The Journal of immunology (1950), 2021-05, Vol.206 (1_Supplement), p.12-12.19

2021

Volltextzugriff (PDF)

Treatment of Lupus Nephritis With Abatacept: The Abatacept and Cyclophosphamide Combination Efficacy and Safety Study

Arthritis & rheumatology (Hoboken, N.J.), 2014-11, Vol.66 (11), p.3096-3104

2014

Volltextzugriff (PDF)

Publisher Correction: The immune cell landscape in kidneys of patients with lupus nephritis

Nature immunology, 2019-10, Vol.20 (10), p.1404-1404

2019

Volltextzugriff (PDF)

Experimental Autoimmune Encephalomyelitis Induced with a Combination of Myelin Basic Protein and Myelin Oligodendrocyte Glycoprotein Is Ameliorated by Administration of a Single Myelin Basic Protein Peptide

The Journal of immunology (1950), 1998-07, Vol.161 (1), p.504-512

1998

Volltextzugriff (PDF)

Minimum Structural Requirements for Peptide Presentation by Major Histocompatibility Complex Class II Molecules: Implications in Induction of Autoimmunity

Proceedings of the National Academy of Sciences - PNAS, 1994-01, Vol.91 (2), p.767-771

1994

Volltextzugriff (PDF)

Antigen recognition in autoimmune encephalomyelitis and the potential for peptide-mediated immunotherapy

Cell, 1989-10, Vol.59 (2), p.247-255

1989

Volltextzugriff (PDF)

A Single Amino Acid Change in a Myelin Basic Protein Peptide Confers the Capacity to Prevent Rather than Induce Experimental Autoimmune Encephalomyelitis

Proceedings of the National Academy of Sciences - PNAS, 1991-11, Vol.88 (21), p.9633-9637

1991

Volltextzugriff (PDF)

Best Available Therapy Versus Autologous Hematopoietic Stem Cell Transplantation for Multiple Sclerosis

Biology of blood and marrow transplantation, 2020-03, Vol.26 (3), p.S297-S297

2020

Volltextzugriff (PDF)

Induction of EAE in mice with recombinant human MOG, and treatment of EAE with a MOG peptide

Journal of neuroimmunology, 1997-05, Vol.75 (1), p.169-173

1997

Volltextzugriff (PDF)

A polyalanine peptide with only five native myelin basic protein residues induces autoimmune encephalomyelitis

The Journal of experimental medicine, 1992-08, Vol.176 (2), p.605-609

1992

Volltextzugriff (PDF)

Antigen Recognition and Peptide-Mediated Immunotherapy in Autoimmune Disease

Immunological reviews, 1990-12, Vol.118 (1), p.37-71

1990

Volltextzugriff (PDF)

Prevention of graft-versus-host disease by peptides binding to class II major histocompatibility complex molecules

Blood, 1994-10, Vol.84 (8), p.2802-2810

1994

Volltextzugriff (PDF)

MHC-binding peptides for immunotherapy of experimental autoimmune disease

Journal of autoimmunity, 1992-04, Vol.5, p.103-113

1992

Volltextzugriff (PDF)

MHC-binding peptides for immunotherapy ofexperimental autoimmune disease

Journal of autoimmunity, 1992-04, Vol.5, p.103-113

1992

Volltextzugriff (PDF)

EAE: A Model for Immune Intervention with Synthetic Peptides

International reviews of immunology, 1992, Vol.9 (3), p.223-230

1992

Volltextzugriff (PDF)

1 – 25 von 32

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(31)
Mit Volltextzugriff
(27)

Publikationsform

Artikel
(32)

Sprache

Englisch
(32)
Japanisch
(3)

Erscheinungsjahr

n.n

Menü

Weitere Dienste

Einstellungen

Predictors of Long‐Term Renal Outcome in Lupus Nephritis Trials: Lessons Learned from the Euro‐Lupus Nephritis Cohort

A CD8 + NK cell transcriptomic signature associated with clinical outcome in relapsing remitting multiple sclerosis

Restoring the balance: immunotherapeutic combinations for autoimmune disease

Immunosuppression causes dynamic changes in expression QTLs in psoriatic skin

Approaches to Establishing Tolerance in Immune Mediated Diseases

Phase II Randomized Trial of Rituximab Plus Cyclophosphamide Followed by Belimumab for the Treatment of Lupus Nephritis

Effect of Costimulatory Blockade With Abatacept After Ustekinumab Withdrawal in Patients With Moderate to Severe Plaque Psoriasis: The PAUSE Randomized Clinical Trial

ACCLAIM: A randomized trial of abatacept (CTLA4-Ig) for relapsing-remitting multiple sclerosis

Solving the puzzle of autoimmunity: critical questions

The immune cell landscape in kidneys of patients with lupus nephritis

Profiling CIS progression and stability using RNA-seq single-cell analysis in peripheral blood mononuclear cells

Treatment of Lupus Nephritis With Abatacept: The Abatacept and Cyclophosphamide Combination Efficacy and Safety Study

Publisher Correction: The immune cell landscape in kidneys of patients with lupus nephritis

Experimental Autoimmune Encephalomyelitis Induced with a Combination of Myelin Basic Protein and Myelin Oligodendrocyte Glycoprotein Is Ameliorated by Administration of a Single Myelin Basic Protein Peptide

Minimum Structural Requirements for Peptide Presentation by Major Histocompatibility Complex Class II Molecules: Implications in Induction of Autoimmunity

Antigen recognition in autoimmune encephalomyelitis and the potential for peptide-mediated immunotherapy

A Single Amino Acid Change in a Myelin Basic Protein Peptide Confers the Capacity to Prevent Rather than Induce Experimental Autoimmune Encephalomyelitis

Best Available Therapy Versus Autologous Hematopoietic Stem Cell Transplantation for Multiple Sclerosis

Induction of EAE in mice with recombinant human MOG, and treatment of EAE with a MOG peptide

A polyalanine peptide with only five native myelin basic protein residues induces autoimmune encephalomyelitis

Antigen Recognition and Peptide-Mediated Immunotherapy in Autoimmune Disease

Prevention of graft-versus-host disease by peptides binding to class II major histocompatibility complex molecules

MHC-binding peptides for immunotherapy of experimental autoimmune disease

MHC-binding peptides for immunotherapy ofexperimental autoimmune disease

EAE: A Model for Immune Intervention with Synthetic Peptides

Suchergebnisse filtern